https://www.cms.gov/files/document/2022-hcpcs-application-summary-quarter-4-2022-drugs-and-biologicals-updated-02/01/2023.pdf
Mizuho Maintains Buy on Kimco Realty, Raises Price Target to $25
Mizuho analyst Haendel St. Juste maintains Kimco Realty (NYSE:KIM) with a Buy and raises the price target from $23 to $25.